Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
27.11
+2.02 (8.05%)
Mar 6, 2026, 11:13 AM EST - Market open
Evommune Market Cap
Evommune has a market cap or net worth of $854.62 million as of March 6, 2026.
Market Cap
854.62M
Enterprise Value
643.27M
1-Year Change
n/a
Ranking
Category
Stock Price
$27.11
Market Cap Chart
Since the IPO on November 6, 2025, Evommune's market cap has increased from $481.24M to $854.62M, an increase of 77.59%. That is a compound annual growth rate of 490.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 743.65M | 37.79% |
| Dec 31, 2025 | 539.69M | 12.15% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Phathom Pharmaceuticals | 844.33M |
| KalVista Pharmaceuticals | 819.86M |
| Xencor | 814.79M |
| Omeros | 814.65M |
| Annexon | 809.37M |
| CytomX Therapeutics | 807.36M |
| BridgeBio Oncology Therapeutics | 797.49M |
| Eikon Therapeutics | 784.93M |